Symptomatic Remission Determines Functional Improvement and Quality of Life in Schizophrenia
- PMID: 28360807
- PMCID: PMC5353039
- DOI: 10.5152/npa.2016.11327
Symptomatic Remission Determines Functional Improvement and Quality of Life in Schizophrenia
Abstract
Introduction: Schizophrenia is a chronic illness that negatively affects the quality of life and psychosocial functions. Defined criteria to assess remission in schizophrenia are considered to be useful in the long-term follow-up of patients and in discriminating diagnostic factors. This study investigated the quality of life and functionality in schizophrenia patients in symptomatic remission (R-Sch) and not in remission (Non-R-Sch).
Methods: Sociodemographic data were collected for 40 R-Sch and 40 Non-R-Sch patients, and the following scales were administered: the Clinical Global Impression-Severity (CGI-S) Scale; Positive and Negative Syndrome Scale (PANSS), World Health Organization Quality of Life Questionnaire-Short Form, Turkish Version (WHOQOL-BREF-TR), Quality of Life Scale for Schizophrenia Patients (QLS), and Global Assessment of Functioning Scale (GAF).
Results: The total and all subscale scores of PANSS and the CGI-S score were significantly lower in the R-Sch group than in the Non-R-Sch group, whereas the GAF scores and all subscales of QLS and WHOQOL-BREF-TR were significantly higher.
Conclusion: This study demonstrates that improvement in symptoms in schizophrenia patients improves quality and functionality in all areas of life, suggesting that an improvement in symptoms is the most important determinant of functional recovery in the treatment of schizophrenia.
Keywords: Schizophrenia; quality of life; symptomatic remission.
Conflict of interest statement
Conflict of Interest: No conflict of interest was declared by the authors.
References
-
- Tarbox SI, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinsenn R, McGlashan TH, Woods SW. Functional development in clinical high risk youth: Prediction of schizophrenia versus other psychotic disorders. Psychiatry Res. 2014;215:52–60. https://doi.org/10.1016/j.psychres.2013.10.006. - DOI - PMC - PubMed
-
- Eren İ, Şimşek D, Çalışkan AM. Şizofreni hastalarında yetiyitimi ve belirti şiddetinin yaşam kalitesine etkisi. Düşünen Adam: Psikiyatri ve Nörolojik Bilimler Dergisi. 2007;20:68–78.
-
- Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441–449. https://doi.org/10.1176/appi.ajp.162.3.441. - DOI - PubMed
-
- Fan X, Henderson DC, Nguyen DD, Cather C, Freudenreich O, Evins AE, Borba C, Goff DC. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia. Psychiatry Res. 2008;159:140–146. https://doi.org/10.1016/j.psychres.2007.10.012. - DOI - PubMed
-
- Priebe S, McCabe R, Junghan U, Kallert T, Ruggeri M, Slade M, Reininghaus U. Association between symptoms and quality of life in patients with schizophrenia: a pooled analysis of changes over time. Schizophr Res. 2011;133:17–21. https://doi.org/10.1016/j.schres.2011.09.021. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous